Company news
Ping An Biomedical Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Ping An Biomedical Announces Planned Acquisition of Three Tumor Cell-Related Medical Technology Patents to Build a Core Oncology and Biotech Intellectual Property Portfolio
October 22, 2026
Ping An Biomedical and Yuan Sheng Mei Yan Sign Strategic Cooperation Agreement, Targeting RMB 500 Million in Sales Over Three Years
July 22, 2026
All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital
March 19, 2026
Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry
January 9, 2026
Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation
January 9, 2026
Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter
November 28, 2025
Majestic Ideal Holdings Ltd Announces Approval of Name Change to "Ping An Biomedical Co., Ltd." at Extraordinary General Meeting
September 11, 2025
Majestic Ideal Holdings Limited Announced Closing of Initial Public Offering
July 21, 2025
Majestic Ideal Holdings Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq
July 16, 2025